Antibodies directed against TNFR2, a regulator in the tumor microenvironment that promotes tumor cell proliferation, have shown promise in T-cell lymphoma and ovarian cancer.
Commentary|Videos|September 11, 2024
Challenges With CAR T-Cell Therapies in T-Cell Lymphomas
Author(s)Jasmine Zain, MD
Jasmine M. Zain, MD, of City of Hope, discuss challenges in CAR-T therapies in patients with T-cell lymphomas.
Advertisement
Jasmine M. Zain, MD, of City of Hope, discuss challenges in CAR-T therapies in patients with T-cell lymphomas.
Advertisement
Related to this article
In case you missed any, read a recap of the episodes of OncLive On Air that aired in July 2026.
Advertisement
Advertisement
Trending on OncLive
1
Dr Wainberg on INCB161734 Activity in Refractory Pancreatic Cancer
2
ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma
3
China’s NMPA Accepts NDA for Opamtistomig in Pretreated Advanced Extrapulmonary NEC
4
Dr Pelster on the Rationale for Investigating Atebimetinib in Metastatic Pancreatic Cancer
5